AMD genotype worth factoring into multifocal IOL candidate selection

AMD genotype worth factoring into multifocal IOL candidate selection

Cataract surgeons would agree that careful patient selection is critical for success with multifocal IOLs. According to Steve Arshinoff, MD, Toronto, Ontario, genetic risk assessment for age-related macular degeneration (AMD) should be among the considerations used when screening patients who are interested in a multifocal IOL.

The issue with implanting a multifocal IOL relates to its effect on decreasing contrast sensitivity. Since AMD also reduces contrast sensitivity, Dr. Arshinoff said he is concerned that there may be a synergistic reduction in contrast sensitivity in an eye with a multifocal IOL that develops even mild AMD.

Therefore, it has become his practice to offer genetic assessment for AMD risk in refractive lens exchange patients and individuals undergoing cataract surgery who want a multifocal IOL. The genetic testing results are then discussed. Patients at high genetic risk for AMD are discouraged from considering multifocal IOLs, but the decision on implant choice is made with the patient.

“The scientific light is just starting to dawn on our understanding of AMD, and with progress in genetic risk assessment for AMD, prediction accuracy now approaches 90%,” said Dr. Arshinoff.

“We need to be careful when making choices for these patients. I believe we should not trade contrast sensitivity to gain depth of field in patients already at high risk for contrast sensitivity loss,” said Dr. Arshinoff.

 

Tags: intraocular pressure
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...